Item Brochure
18 19
Thanks to CoaguChek® you have the
reassurance and peace of mind of always
knowing your INR value when needed.
Patient self-monitoring enables more regular
checks and dosage adjustment if necessary,
therefore improving the time spent within
your therapeutic range.
38
You can manage your anticoagulation
therapy wherever you are, whatever you do.
There’s no need to change your routine
to fit in clinic appointments.
If you want to make sure you are in
complete control of your anticoagulation
therapy, start patient self-monitoring to
make this a reality.
1 http://www.stoptheclot.org/learn_more/blood_clot_treatment.htm last accessed June 2012
2 http://www.ismaap.org/ last accessed June 2012
3 Wardrop D et al (2008) Br J Haematol 141:757-763
4 Fiumara K et al (2009) Circulation 119:e220-e222
5 Hart R et al (2007) Ann Intern Med 146:857-867
6 http://www.nhs.uk/Conditions/Anticoagulant-medicines/Pages/How-does-it-work.aspx last accessed June 2012
7 Moualla H et al (2011) romb Res 128:210-215
8 Wan J Y et al (2011) J Am Coll Cardiol 57:1330-1337
9 Ryan J et al (2008) J Clin Pharm erap 33:581-590)
10 Levi M et al (2009) Semin romb Hemost 35:527-542
11 Kannel & Benjamin (2009) Cardiol Clin 27(1):13-24
12 http://www.nlm.nih.gov/medlineplus/ency/article/000184.htm last accessed June 2012
13 http://www.nhs.uk/conditions/Atrial-brillation/Pages/Introduction.aspx last accessed June 2012
14 http://www.nhs.uk/Conditions/Atrial-brillation/Pages/Symptoms.aspx last accessed June 2012
15 http://www.nhs.uk/Conditions/Atrial-brillation/Pages/Treatment.aspx last accessed June 2012
16 Cannon C P et al (2010) Am J Manag Care 16:S273-S277
17 Medi C et al (2010) Stroke 41:2705-2713
18 Shea J B et al (2008) Circulation 117:e340-e343
19 http://www.stroke.org/site/PageServer?pagename=stroke last accessed June 2012
20 Schulman S (2012) J R Coll Physicians Edinb 42:51–5
21 http://www.bhf.org.uk/heart-health/conditions/heart-valve-disease.aspx last accessed June 2012
22 Maganti K et al (2010) Mayo Clin Proc 85:483-500
23 Bloomeld P et al (2002) Heart 87:583–589
24 Keeling DM et al (2011) Br J Haematol 154:311-324
25 http://www.anticoagulation.com.au/AboutWarfarin/WhyTakeWarfarin/ArticialHeartValves/tabid/102/
Default.aspx last accessed June 2012
26 Anderson FA (2003). Circulation 107:9-16
27 Kearon C et al (2008) Chest 133:454S-545S
28 Galson SK et al (2008) Public Health Rep 123:420-421
29 Sadeghi A et al (2005) Tex Heart Inst J 32:430-433
30 McManus RA et al (2010) Clin Evid (online) Mar 8;2011. pii: 0208
31 http://www.anticoagulation.com.au/AboutWarfarin/INREssentials/WhatistheINR/tabid/106/Default.aspx
last accessed June 2012
32 Atrial Fibrillation Association Australia Warfarin erapy Fact Sheet
33 Hirsch J et al (2001) Chest 119:8S-21S
34 Murray E et al (2004) Br J Haematol 127:373-378
35 Heneghan C et al (2012) Lancet 379:322-334
36 Bloomeld HE et al (2011) Ann Int Med 154:472-482
37 Bernardo A. (2000) Optimising long-term anticoagulation by patient self-management and management
by specialist anticoagulation clinic. A randomised cross over comparison. Lancet 356:97-102